dihydrokainate has been researched along with zm 241385 in 1 studies
Studies (dihydrokainate) | Trials (dihydrokainate) | Recent Studies (post-2010) (dihydrokainate) | Studies (zm 241385) | Trials (zm 241385) | Recent Studies (post-2010) (zm 241385) |
---|---|---|---|---|---|
180 | 0 | 46 | 401 | 3 | 124 |
Protein | Taxonomy | dihydrokainate (IC50) | zm 241385 (IC50) |
---|---|---|---|
Adenosine receptor A3 | Rattus norvegicus (Norway rat) | 0.0949 | |
Adenosine receptor A2a | Homo sapiens (human) | 0.0216 | |
Adenosine receptor A2b | Homo sapiens (human) | 0.0646 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Galluzzo, M; Grieco, R; Pèzzola, A; Pintor, A; Popoli, P; Reggio, R | 1 |
1 other study(ies) available for dihydrokainate and zm 241385
Article | Year |
---|---|
Adenosine A 2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors.
Topics: Adenosine A2 Receptor Antagonists; Animals; Corpus Striatum; Dicarboxylic Acids; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Excitatory Amino Acid Transporter 2; Glutamic Acid; Kainic Acid; Male; Microdialysis; Neuroprotective Agents; Neurotransmitter Uptake Inhibitors; Pyrimidines; Pyrrolidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Triazines; Triazoles | 2004 |